Johan Cardoen
Director/Board Member bij BIOTALYS NV
Oorsprong van het eerstegraads netwerk van Johan Cardoen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Université Catholique de Louvain
75
| College/University | Other Consumer Services | 75 |
23
| Public Company | Chemicals: Agricultural | 23 |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium.
15
| Subsidiary | Miscellaneous Commercial Services | 15 |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.
15
| Subsidiary | Biotechnology | 15 |
PBL-Ventures
 PBL-Ventures Investment ManagersFinance PBL-Ventures is the business start-up and mentoring arm of Plant Bioscience Ltd founded in 1994. The firm is headquartered in the UK.
7
| Operating Division | Investment Managers | 7 |
Applied Maths NV
 Applied Maths NV Packaged SoftwareTechnology Services Applied Maths NV develops software for the biosciences. It offers desktop software such as BioNumerics, GelCompar II, GeneMaths XT, and Kodon. It also offers server software such as BioNumerics server. The firm also offers services such as training workshops, on-site training, data analysis, and scripts development. The company was founded by Paul Vauterin and Luc Vauterin in 1992 and is headquartered in Sint-Martens-Latem, Belgium.
7
| Subsidiary | Packaged Software | 7 |
Meiogenix SAS
 Meiogenix SAS BiotechnologyHealth Technology Meiogenix SAS operates as a biotech company which develops breeding technologies. Its technology allows the modulation of the homologous recombination in eukaryotic cells. It facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties. The company was founded by Giacomo Bastianelli and Alain Nicolas in 2011 and is headquartered in Paris, France.
6
| Holding Company | Biotechnology | 6 |
Plant Bioscience Ltd.
 Plant Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Plant Bioscience Ltd. operates as an independent technology management company. The firm specializes in plant, food and microbial science. Its services include identification of opportunities, enhancement and protection of technology, commercialization strategy and business development. The company was founded in 1994 and is headquartered in Norwich, the United Kingdom.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Corgo NV
 Corgo NV Miscellaneous Commercial ServicesCommercial Services Corgo NV specializes in corporate consulting services. The company determines the required profiles for client’s new directors, engages a network of professional external directors, recommends suitable candidates, and refers search specialists. It was founded by Karel Plasman in 2003 and is headquartered in Brussels, Belgium.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.
4
| College/University | Other Consumer Services | 4 |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Johan Cardoen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALTRAN TECHNOLOGIES | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| TIGENIX NV | Medical Specialties | Founder Director/Board Member Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Masters Business Admin | |
| BEKAERT NV | Metal Fabrication | Corporate Officer/Principal Chief Operating Officer | |
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Zeneca Garden Care
 Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The private company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
| ZETES INDUSTRIES | Information Technology Services | Director/Board Member Sales & Marketing | |
| University of Birmingham | College/University | Graduate Degree Doctorate Degree | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member | |
Gimv (Private Equity)
 Gimv (Private Equity) Investment ManagersFinance Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Leiden | College/University | Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Utrecht | College/University | Undergraduate Degree Doctorate Degree | |
| Ghent University | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Chief Operating Officer | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| Université Libre de Bruxelles | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University College Cork | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Vlerick Leuven Gent Management School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| OXURION NV | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
| The Janssen Research Foundation | President Chief Tech/Sci/R&D Officer | ||
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member | |
Bio-Incubator Leuven
 Bio-Incubator Leuven Real Estate DevelopmentFinance Bio-Incubator Leuven is a dynamic and innovative environment that provides lab space and support to R&D-intensive life sciences companies. The private company offers customizable modules that can be modified to meet the specific requirements of each client. The company is based in Leuven, Belgium. Leuven's knowledge institutes, including KU Leuven, University Hospitals Leuven, VIB, and IMEC, generate a huge outflow of knowledge that entails a myriad of innovative ideas for new and existing companies. The CEO of the Belgian company is Michaël de Blauwe. | Real Estate Development | Director/Board Member Director/Board Member | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Bayer Bioscience NV
 Bayer Bioscience NV Chemicals: AgriculturalProcess Industries Part of Bayer AG, Bayer Bioscience NV is a Belgian company that manufactures and markets herbicides and agricultural chemical products. The private company is based in Ghent, Belgium. The company was founded by Gerard van Acker. | Chemicals: Agricultural | Corporate Officer/Principal Corporate Officer/Principal | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Federatie Voedingsindustrie FEVIA | Director/Board Member | ||
| University of Antwerp | College/University | Undergraduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal | |
BioActor BV
 BioActor BV Chemicals: SpecialtyProcess Industries BioActor BV develops and markets health ingredients for dietary supplements and functional foods. Its products include BONOLIVE, CORDIART and NAXUS. The company was founded by Hans Van Der Saag in 2005 and is headquartered in Maastricht, the Netherlands. | Chemicals: Specialty | President Chief Executive Officer | |
Q-Biologicals NV
 Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
20Med Therapeutics BV
 20Med Therapeutics BV BiotechnologyHealth Technology 20Med Therapeutics BV operates as a biomedical company. It focuses on the development of biodegradable materials for biomedical applications and multifunctional nanosystems for controlled drug and gene delivery. The company was founded by Johan F. J. Engbersen in 2011 and is headquartered in Enschede, the Netherlands. | Biotechnology | Chairman Director/Board Member | |
KeBeK Management NV
 KeBeK Management NV Investment ManagersFinance KeBeK Management NV (KeBeK) is an independent private equity firm headquartered in Grimbergen, Belgium. The firm was founded by Floris Vansina, Gert Van Huffel, Ast Verbiest, and Gerd Smeets in 2012. | Investment Managers | Founder Founder | |
MaSTherCell SA
 MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Asbest Partners België BV
 Asbest Partners België BV HomebuildingConsumer Durables Asbest Partners België BVBA provides asbestos abatement & removal supplies services. The company was founded in November 2008 and is headquartered in Westerlo, Belgium. | Homebuilding | Director/Board Member Director/Board Member | |
Keluda BV
 Keluda BV Financial ConglomeratesFinance Keluda BV is an investment holding Belgian company that provides business and office administrative services. The private company is based in Westerlo, Belgium. Keluda was founded in 2019 and the CEO is Floris Maria Cyriel Suzanne Vansina. | Financial Conglomerates | Chief Executive Officer Director/Board Member |
Statistieken
Internationaal
| België | 31 |
| Frankrijk | 7 |
| Nederland | 6 |
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 4 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 4 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 373 |
| Corporate Officer/Principal | 145 |
| Chief Executive Officer | 75 |
| Chairman | 70 |
| Graduate Degree | 43 |
Sterkste connecties
| Insiders | |
|---|---|
| Chris Buyse | 39 |
| Jean-Paul Prieels | 32 |
| Catherine Moukheibir | 29 |
| Willem Frans Alfons van Twembeke | 29 |
| Patrick van Beneden | 28 |
| Mounia Chaoui-Roulleau | 27 |
| Lian Yong Chen | 24 |
| Staf van Reet | 22 |
| Jean Eylenbosch | 21 |
| Harrold van Barlingen | 20 |
| Christine Morris | 19 |
| Gil Beyen | 18 |
| Thierry Laugel | 18 |
| Kevin W. Wolfe | 17 |
| Jos Sluys | 17 |
- Beurs
- Insiders
- Johan Cardoen
- Bedrijfsconnecties
